Updated Viloxazine Pharmacology: Experiments Establish Norepinephrine Transporter Occupancy and Serotonin 5-HT<sub>2C</sub>, 5-HT<sub>2B</sub>, and 5-HT<sub>7</sub> Receptor Binding at Therapeutically Relevant Concentrations. [PDF]
Garcia-Olivares J +4 more
europepmc +1 more source
Possible Involvement of Hallucinogenic Effects in the Aversive Effects Induced by Kappa-Opioid and 5-HT<sub>2A</sub> <sub>/2C</sub> Receptor Agonists in Mice. [PDF]
Kato H +5 more
europepmc +1 more source
The renaissance of research on psychedelics in child and adolescent psychopharmacology. [PDF]
Crocq MA, Auby P.
europepmc +1 more source
Pharmacological Interventions in Autism Spectrum Disorder: A Comprehensive Review of Mechanisms and Efficacy. [PDF]
Sclabassi E, Peret S, Qian C, Gao Y.
europepmc +1 more source
Psychedelic 5-HT2A agonist increases spontaneous and evoked 5-Hz oscillations in visual and retrosplenial cortex. [PDF]
White CM +5 more
europepmc +1 more source
The ABCs of psychedelics: a preclinical roadmap for drug discovery. [PDF]
Kwan AC, Mantsch JR, McCorvy JD.
europepmc +1 more source
Molecular Mechanisms of Emerging Antidepressant Strategies: From Ketamine to Neuromodulation. [PDF]
Kowalczyk M +5 more
europepmc +1 more source
Prospects of Using Platelets as Peripheral Marker to Study the Role of GABA in Autism [PDF]
Fatima-Shad, K, Ghouse, HP, Khan, S
core +1 more source
Impact of Antidepressants on Weight Gain: Underlying Mechanisms and Mitigation Strategies. [PDF]
Mouawad M, Nabipur L, Agrawal DK.
europepmc +1 more source
Serotonin (5-Hydroxytryptamine): Metabolism, Signaling, Biological Functions, Diseases, and Emerging Therapeutic Opportunities. [PDF]
Zhang Y +7 more
europepmc +1 more source

